CVS HEALTH CORPORATION (CVS) Financial Statements
Historical financial data — 42 statements covering FY2016–FY2025
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy bene...
CVS HEALTH CORPORATION's revenue increased 7.8% year over year, from $372.81B to $402.07B.
Net income decreased 61.7% over the same period, from $4.61B to $1.77B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 126% in total.
Total debt remained relatively stable at $60.50B.
The debt-to-equity ratio stands at 0.80, indicating a moderate leverage profile.
Operating cash flow grew 16.8% to $10.64B.
CVS HEALTH CORPORATION maintains a moderate net profit margin of 0.4%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $95.43B+4.6% | $87.0M | $42.48B | $832.0M | $-745.0M | $252.43B | $60.62B | $74.94B |
| Q4 FY2024 | $97.71B+2.4% | $1.64B | $42.44B | $2.37B | $1.86B | $253.22B | $62.65B | $75.56B |
| Q1 FY2025 | $94.59B-3.2% | $1.78B | $43.53B | $3.37B | $4.56B | $255.59B | $60.30B | $76.93B |
| Q2 FY2025 | $98.92B+4.6% | $1.02B | $44.91B | $2.38B | $1.90B | $258.34B | $60.33B | $77.38B |
| Q3 FY2025 | $102.87B+4.0% | $-3.98B | $45.83B | $2.61B | $796.0M | $255.33B | $61.76B | $72.93B |
| Q4 FY2025 | $105.69B+2.7% | $2.94B | $46.63B | $1.65B | $3.39B | $253.54B | $60.50B | $75.21B |
| Q1 FY2026 | $100.43B-5.0% | $2.94B | $44.98B | $4.68B | $4.25B | $252.97B | $78.34B | $77.64B |
| Q2 FY2026 | $106.10B+5.6% | $2.98B | $47.23B | $4.70B | $6.34B | $253.77B | $76.31B | $79.90B |
Balance Sheet Summary (Q2 FY2026)
CVS HEALTH CORPORATION (CVS) Financial Statements & Revenue History
CVS HEALTH CORPORATION (CVS) is a US-listed stock operating in the Healthcare sector, specifically the Healthcare Plans industry trading at $92.37 with a market capitalization of $118. This page provides 42 historical financial statements for CVS HEALTH CORPORATION, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, CVS HEALTH CORPORATION reported revenue of $402.1 billion, representing 7.8% year-over-year growth. The net profit margin of 0.4% suggests thin margins. The debt-to-equity ratio of 0.80 reflects moderate leverage.
CVS Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows CVS HEALTH CORPORATION's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether CVS is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track CVS's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently CVS HEALTH CORPORATION converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of CVS's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use CVS Financial Data
Investors use CVS HEALTH CORPORATION's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare CVS's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how CVS's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View CVS's financial health score, earnings, and pre-market pricing.
Financial data is sourced from CVS HEALTH CORPORATION's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.CVS trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.